Search bioRxiv⌕ Search

Biology subjects

Erkelenz, M.

Publications and source records attributed to Erkelenz, M..

2 recordsLinked to original sources

Membrane Proteins at Scale: Automated Copolymer Nanodisc Purification for Structure and Function

Membrane proteins remain among the most important yet least accessible classes of drug targets. Conventional detergents can remove native lipids, destabilizing proteins and limiting downstream biochemistry and structural biology. Amphiphilic copolymers offer a powerful alternative, directly extracting membrane proteins in their native lipid environment, but solubilization outcomes remain unpredictable, turning each new target into a slow empirical search. Here, we introduce an automated, plate-based copolymer screening platform that compresses this process from days to hours using millilitre-scale volumes. Lyophilized copolymer libraries combined with magnetic-bead affinity purification enable parallel testing of dozens of copolymers against multiple targets; across 14 diverse human membrane proteins, next-generation copolymers (AASTY, CyclAPol and Cubipol) systematically outperform classical scaffolds. In this work, we show that this automated copolymer screening robustly identifies the right target-copolymer combination, yielding native-like, active, ligand-binding competent protein suitable for structure determination, and establishes a scalable route to systematic exploration of the membrane proteome.

biochemistry↗

A non-autonomous protein quality control mechanism targeting tau aggregate propagation

Tauopathies such as Alzheimers disease, frontotemporal dementia with Parkinsonism, and other neurodegenerative disorders are characterized by the spread of tau pathology from an initial brain region to neuroanatomically connected areas. At the molecular level, spreading involves aggregation of tau in a donor cell, externalization of transmissible fragments of amyloid fibrils, internalization by an acceptor cell, followed by seeded aggregation of endogenous tau. However, the protein quality control mechanisms that counteract tau aggregation, and in particular its spreading process, are not well understood. In this context, a co-migrating factor performing location-independent interference of fibril formation and transmission would be an appropriate conceptual solution. Here, we show that the cell-to-cell transfer of the widely conserved serine protease HTRA1 impedes tau pathology by targeting multiple steps within the spreading process. Our results suggest a defense mechanism against the intercellular spread of pathogenic protein conformations.

biochemistry↗